(Q46745741)

English

Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18284403

Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18284403

atopic dermatitis

1 reference

based on heuristic

inferred from title

methylprednisolone

1 reference

based on heuristic

inferred from title

author name string

A Peserico

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18284403

G Städtler

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18284403

M Sebastian

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18284403

R Suarez Fernandez

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18284403

K Vick

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18284403

T Bieber

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18284403

language of work or name

0 references

publication date

16 February 2008

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18284403

British Journal of Dermatology

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18284403

158

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18284403

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18284403

801-807

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18284403

Position paper on diagnosis and treatment of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08436.X

21 January 2018

Randomised controlled trial of short bursts of a potent topical corticosteroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08436.X

21 January 2018

Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08436.X

21 January 2018

Methylprednisolone aceponate in eczema and other inflammatory skin disorders -- a clinical update

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08436.X

21 January 2018

Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08436.X

21 January 2018

The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08436.X

21 January 2018

Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08436.X

21 January 2018

Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08436.X

21 January 2018

Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08436.X

21 January 2018

Skin barrier dysfunction and systemic sensitization to allergens through the skin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08436.X

21 January 2018

Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08436.X

21 January 2018

Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08436.X

21 January 2018

The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate. The Netherlands Adult Atopic DermatitisStudy Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08436.X

21 January 2018

Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08436.X

21 January 2018

Atopic dermatitis and asthma: parallels in the evolution of treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08436.X

21 January 2018

An open study of efficacy and safety of long-term treatment with mometasone furoate fatty cream in the treatment of adult patients with atopic dermatitis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08436.X

21 January 2018

Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08436.X

21 January 2018

Evaluation of mite allergen-induced Th1 and Th2 cytokine secretion of peripheral blood mononuclear cells from atopic dermatitis patients: association between IL-13 and mite-specific IgE levels

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08436.X

21 January 2018

IL-31: a new link between T cells and pruritus in atopic skin inflammation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08436.X

21 January 2018

Identifiers

10.1111/J.1365-2133.2008.08436.X

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18284403

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18284403

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46745741&oldid=2129605505"